Solithera (Solithromycin) is a next-generation macrolide antibiotic developed by Cempra. Solithromycin is a ketolide antibiotic undergoing clinical development for the treatment of community-acquired pneumonia (CABP) and other infections. It has efficacy in vitro against the common causative pathogens including Streptococcus pneumoniae, Haemophilus influenzae, and atypical pathogens.
Antibiotics & Antibacterials
|Price||Custom packed. Request price on line.|
|MDL Number||Request if not shown|
Send us your enquiry for Solithromycin (CEM-101). We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Solithromycin (CEM-101) email us and we will include your contribution on the website.